GLUCOSE-DEPENDENCY OF THE INSULIN STIMULATORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36) AMIDE ON THE RAT PANCREAS

被引:75
|
作者
GOKE, R [1 ]
WAGNER, B [1 ]
FEHMANN, HC [1 ]
GOKE, B [1 ]
机构
[1] UNIV MARBURG,DEPT INTERNAL MED,DIV GASTROENTEROL,MOLEC ENDOCRINOL LAB,W-3550 MARBURG,GERMANY
关键词
GLUCAGON-LIKE PEPTIDE-1; ISLETS; PERFUSED PANCREAS; INSULIN SECRETION; GLUCOSE DEPENDENCY;
D O I
10.1007/BF02576216
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The glucose-dependent action of GLP-1 (7-36) amide (GLP-1) on insulin secretion was studied in isolated islets and in the perfused rat pancreas. In islet experiments in the presence of non-stimulatory glucose levels (< 3 mmol/1) a GLP-1 concentration of 10 nmol/l increased insulin secretion by 83%. However, higher GLP-1 concentrations (25 and 100 nmol/1) could not further enhance this effect (85 and 83%, respectively). The onset of the stimulatory action of a supramaximal GLP-1-load (25 nmol/1) was at a glucose level of 3 mmol/l. In the perfused pancreas, 25 nmol/l GLP-1 induced a strong insulin release at 5 mmol/l glucose, but under basal glucose (2.8 mmol/1) only a slight enhancement of insulin secretion occurred during the late phase (30 to 54 min) of perfusion (P < 0.05). In conclusion, a slight but not dose-dependent stimulation of insulin secretion by supramaximal GLP-1 loads under basal glucose levels was found. The necessary GLP-1 concentrations to achieve this in vitro effect are beyond physiological or postprandial levels.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 50 条
  • [31] SOLUBILIZATION OF ACTIVE RECEPTORS FOR GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE FROM RAT LUNG MEMBRANES
    GOKE, R
    KOLLIGS, F
    RICHTER, G
    LANKATBUTTGEREIT, B
    GOKE, B
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02): : L146 - L152
  • [32] INTERACTION OF GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE AND GASTRIC-INHIBITORY POLYPEPTIDE OR CHOLECYSTOKININ ON INSULIN AND GLUCAGON-SECRETION FROM THE ISOLATED PERFUSED RAT PANCREAS
    SUZUKI, S
    KAWAI, K
    OHASHI, S
    WATANABE, Y
    YAMASHITA, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (04): : 359 - 363
  • [33] Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes
    Vella, A
    Shah, P
    Basu, R
    Basu, A
    Holst, JJ
    Rizza, RA
    [J]. DIABETES, 2000, 49 (04) : 611 - 617
  • [34] Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans
    Schirra, J
    Sturm, K
    Leicht, P
    Arnold, R
    Göke, B
    Katschinski, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07): : 1421 - 1430
  • [35] Glucagon-like peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice
    Linn, T
    Schneider, K
    Goke, B
    Federlin, K
    [J]. ACTA DIABETOLOGICA, 1996, 33 (01) : 19 - 24
  • [36] GLUCAGON-LIKE PEPTIDE-1 (7-36) AMIDE STIMULATES INSULIN AND GLUCOKINASE GENE-EXPRESSION IN-VIVO
    WANG, YH
    HENDERSON, TE
    EGAN, JM
    [J]. DIABETES, 1995, 44 : A75 - A75
  • [37] Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes
    Meneilly, GS
    McIntosh, CHS
    Pederson, RA
    Habener, JF
    Ehlers, MRW
    Egan, JM
    Elahi, D
    [J]. DIABETES CARE, 2003, 26 (03) : 837 - 842
  • [38] Glucagon-like peptide-1(7-36) amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes
    Miki, H
    Namba, M
    Nishimura, T
    Mineo, I
    Matsumura, T
    Miyagawa, J
    Nakajima, H
    Kuwajima, M
    Hanafusa, T
    Matsuzawa, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1996, 1312 (02): : 132 - 136
  • [39] BIOLOGICAL EFFECTS AND METABOLIC RATES OF GLUCAGON-LIKE PEPTIDE-1 7-36 AMIDE AND GLUCAGON-LIKE PEPTIDE-1 7-37 IN HEALTHY-SUBJECTS ARE INDISTINGUISHABLE
    ORSKOV, C
    WETTERGREN, A
    HOLST, JJ
    [J]. DIABETES, 1993, 42 (05) : 658 - 661
  • [40] Mechanisms involved in glucagon-like peptide-1 (7-36) amide action on the rat hypothalamo-neurohypophysial system
    Bojanowska, E
    Stempniak, B
    [J]. NEUROENDOCRINOLOGY, 2003, 77 (02) : 119 - 124